Barclays
MDRX

Barclays’s Veradigm Inc. Common Stock MDRX Stock Holding History

Barclays’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-459,482
Closed -$3.54M – 5443
2024
Q1 		$3.54M Buy
459,482
+183,940
+67% +$1.67M ﹤0.01% 2089
2023
Q4 		$2.89M Buy
275,542
+138,733
+101% +$1.7M ﹤0.01% 2602
2023
Q3 		$1.8M Sell
136,809
-39,265
-22% -$515K ﹤0.01% 1964
2023
Q2 		$2.22M Sell
176,074
-41,058
-19% -$499K ﹤0.01% 1824
2023
Q1 		$2.83M Buy
217,132
+7,681
+4% +$124K ﹤0.01% 1935
2022
Q4 		$3.69M Buy
209,451
+12,716
+6% +$213K ﹤0.01% 1840
2022
Q3 		$3M Buy
196,735
+55,445
+39% +$897K ﹤0.01% 1476
2022
Q2 		$2.1M Sell
141,290
-41,721
-23% -$780K ﹤0.01% 1829
2022
Q1 		$4.12M Sell
183,011
-97,543
-35% -$1.98M ﹤0.01% 1354
2021
Q4 		$5.18M Buy
280,554
+1,547
+0.6% +$24.6K ﹤0.01% 1685
2021
Q3 		$3.73M Buy
279,007
+148,884
+114% +$2.4M ﹤0.01% 1829
2021
Q2 		$2.41M Sell
130,123
-108,291
-45% -$1.82M ﹤0.01% 2073
2021
Q1 		$3.58M Buy
238,414
+61,540
+35% +$985K ﹤0.01% 1799
2020
Q4 		$2.56M Sell
176,874
-20,732
-10% -$251K ﹤0.01% 2049
2020
Q3 		$1.61M Sell
197,606
-3,490
-2% -$28.5K ﹤0.01% 2285
2020
Q2 		$1.36M Buy
201,096
+129,425
+181% +$839K ﹤0.01% 2474
2020
Q1 		$504K Sell
71,671
-123,752
-63% -$1M ﹤0.01% 3583
2019
Q4 		$1.92M Buy
195,423
+85,596
+78% +$901K ﹤0.01% 3045
2019
Q3 		$1.21M Sell
109,827
-38,739
-26% -$398K ﹤0.01% 3480
2019
Q2 		$1.73M Buy
148,566
+94,696
+176% +$963K ﹤0.01% 3096
2019
Q1 		$514K Sell
53,870
-1,821
-3% -$20.1K ﹤0.01% 4089
2018
Q4 		$537K Sell
55,691
-95,283
-63% -$1.06M ﹤0.01% 3739
2018
Q3 		$2.15M Buy
150,974
+59,909
+66% +$814K ﹤0.01% 2793
2018
Q2 		$1.09M Sell
91,065
-17,594
-16% -$217K ﹤0.01% 3185
2018
Q1 		$1.34M Sell
108,659
-54,591
-33% -$776K ﹤0.01% 2871
2017
Q4 		$2.37M Sell
163,250
-153,696
-48% -$2.14M ﹤0.01% 2277
2017
Q3 		$4.51M Sell
316,946
-93,965
-23% -$1.22M ﹤0.01% 1613
2017
Q2 		$5.24M Buy
410,911
+23,788
+6% +$289K 0.01% 1430
2017
Q1 		$4.91M Sell
387,123
-19,608
-5% -$232K 0.01% 1342
2016
Q4 		$4.15M Buy
406,731
+388,877
+2,178% +$4.44M ﹤0.01% 1529
2016
Q3 		$235K Sell
17,854
-32,696
-65% -$437K ﹤0.01% 3830
2016
Q2 		$642K Buy
50,550
+4,994
+11% +$66.2K ﹤0.01% 2988
2016
Q1 		$591K Buy
45,556
+12,946
+40% +$170K ﹤0.01% 3011
2015
Q4 		$489K Sell
32,610
-8,784
-21% -$126K ﹤0.01% 3240
2015
Q3 		$497K Sell
41,394
-29,958
-42% -$412K ﹤0.01% 3346
2015
Q2 		$928K Buy
71,352
+66,447
+1,355% +$897K ﹤0.01% 2942
2015
Q1 		$54K Sell
4,905
-4,454
-48% -$54.4K ﹤0.01% 5229
2014
Q4 		$113K Buy
9,359
+574
+7% +$7.31K ﹤0.01% 5107
2014
Q3 		$115K Sell
8,785
-54,086
-86% -$820K ﹤0.01% 5218
2014
Q2 		$1.01M Buy
62,871
+54,514
+652% +$850K ﹤0.01% 3337
2014
Q1 		$151K Sell
8,357
-10,886
-57% -$188K ﹤0.01% 5062
2013
Q4 		$290K Buy
19,243
+9,568
+99% +$141K ﹤0.01% 4630
2013
Q3 		$135K Sell
9,675
-5,009
-34% -$75.5K ﹤0.01% 5383
2013
Q2 		$190K Buy
+14,684
New +$197K ﹤0.01% 5224

Other funds holding MDRX

Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
IC
Innealta Capital Austin, Texas $161M AUM 23.8% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FRA
Front Row Advisors Tiburon, California $296M AUM 34.73% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's MDRX Position: Q2 2024 in Review

Barclays sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2024, closing a stake of 459,482 shares — an estimated $3.54M sold.

Barclays first reported a position in MDRX in Q2 2013 and held it in 44 quarters. The position peaked at $5.24M in Q2 2017. 10 funds tracked by Wall St. Rank hold MDRX as of Q2 2024.

  • Barclays reported no remaining Veradigm Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Barclays sold 459,482 Veradigm Inc. Common Stock shares in Q2 2024, an estimated $3.54M.
  • Barclays first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 44 quarters.
  • Barclays's Veradigm Inc. Common Stock position peaked at $5.24M in Q2 2017.
  • 10 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2024.

Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.